Symbol="PBYI"
AssetType="Common Stock"
Name="Puma Biotechnology Inc"
Description="Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California."
CIK="1401667"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10880 WILSHIRE BLVD., SUITE 2150, LOS ANGELES, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="166744000"
EBITDA="45173000"
PERatio="32.45"
PEGRatio="0.03"
BookValue="0.554"
DividendPerShare="0"
DividendYield="0"
EPS="0.11"
RevenuePerShareTTM="5.13"
ProfitMargin="0.0204"
OperatingMarginTTM="0.152"
ReturnOnAssetsTTM="0.113"
ReturnOnEquityTTM="0.291"
RevenueTTM="235070000"
GrossProfitTTM="172938000"
DilutedEPSTTM="0.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.154"
AnalystTargetPrice="4.75"
TrailingPE="32.45"
ForwardPE="11.29"
PriceToSalesRatioTTM="1.045"
PriceToBookRatio="9.06"
EVToRevenue="1.092"
EVToEBITDA="7.87"
Beta="1.048"
num_52WeekHigh="5.16"
num_52WeekLow="2.08"
num_50DayMovingAverage="3.323"
num_200DayMovingAverage="3.447"
SharesOutstanding="46707000"
DividendDate="None"
ExDividendDate="None"
symbol="PBYI"
open="3.53"
high="3.62"
low="3.53"
price="3.57"
volume="74716.00"
latest_trading_day="2023-07-25"
previous_close="3.55"
change="0.02"
change_percent="0.5634%"
aroon_positive_momentum_days="38"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="275207"
Change_recent_avg="-0.01"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_negative_thumbnail_id_2="492"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="601"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0107.jpeg"
image_positive_thumbnail_id_2="625"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0083.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
